Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi to Expand the Platform's Reach across MENA

AMMAN, Jordan, March 28, 2022 /PRNewswire/ -- Hikma Pharmaceuticals PLC ('Hikma' or 'Group'), the multinational pharmaceutical company, announces that its venture capital arm, Hikma Ventures, has participated in the Series B financing round for Altibbi; the leading publisher of Arabic medical content globally - with two million pages of medical content, twenty million unique visitors per month and three million consultations per year. The company will use the proceeds from this round to grow the team, invest in talent and technology, as well as launch new products across the Middle East and North Africa (MENA) region.

"We are very impressed with what the Altibbi team has been able to achieve to date. The company has grown rapidly during the past few years because it is solving real problems by adding features and products based on the needs of users. In addition, their platform has proven to be highly scalable during the pandemic as the company handled exponential growth," commented Lana Ghanem, Managing Director at Hikma Ventures. "On the strategic end, Hikma has already partnered with Altibbi in Jordan, Egypt and Lebanon. We are proud to support the largest mission-driven digital health platform in MENA that is helping patients in the Arab World and are looking forward to being part of the next chapter."

Jalil Allabadi, Co-Founder and CEO of Altibbi, said, "Altibbi is proud to have a strategic investor like Hikma, the leading pharmaceutical company in MENA, with whom we share the same mission of making higher quality healthcare accessible to everyone. We are looking forward to working with their team and leveraging their global experience in digital health to further expand our platform."

Altibbi is an end-to-end digital health platform that provides telehealth consultations; booking and data management software solutions for doctors; a specialist doctor marketplace; in addition to drug delivery services. The company has been able to achieve a market-leading position with capital efficiency and rigor against competitors. It is the first and largest telemedicine platform in the Arab World; the first to be recognized as an official telehealth provider in Egypt, Jordan and the UAE. Altibbi is revolutionizing healthcare in MENA along the three critical axes of access, quality and affordability.

About Hikma:
Hikma helps put better health within reach every day for millions of people around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,700 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com

About Hikma Ventures
Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Hikma Ventures invests in global startups where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company.

For more information, please visit: www.hikmaventures.com

About Altibbi
The first and largest platform in the Arab region that offers telemedicine consultation services, allowing patients to connect directly with doctors via audio calls and chats. Stemming from the fact that there are approximately 400 million people in the Arab World lacking access to essential medical services, Altibbi works diligently to circulate medical content in the Arabic Language via the Internet. By providing medical information from trusted sources and remote medical consultation services for all Arabic speakers, Altibbi helps patients access medical information and advice, thus reducing the number of unnecessary doctor visits and lessening the pressure on the healthcare system. For more information, please visit: www.altibbi.com 

SOURCE Hikma Pharmaceuticals USA Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED